Position in LGND
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$20,879,395
-$6,170,282 QoQ
Shares Held
104,580
-26.9% QoQ
Ownership
0.522%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 94.33830560336585.ToString("F0")%
Shared 0.ToString("F0")%
None 5.6616943966341555.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Derivatives in LGND
reported options exposure · as of Jun 30, 2021CallValue
$736,562
CallShares
9,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. LGND ranks #69 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in LGND
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,879,395 | 104,580 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $27,049,677 | 143,067 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $19,837,198 | 111,986 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,809,416 | 33,510 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,200,039 | 30,436 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,904,300 | 27,105 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,150,734 | 11,497 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,268,107 | 38,786 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,416,904 | 33,063 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,358,908 | 19,027 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $414,406 | 6,916 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $582,207 | 8,075 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $86,873 | 1,181 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $110,888 | 1,660 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $19,338 | 360 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $37,289 | 670 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $2,195,344 | 31,284 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,588,914 | 26,868 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,341,581 | 26,942 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $787,549 | 9,623 | Shares | Defined | 2021-08-13 | |
| 2021-06-30 | $736,562 | 9,000 | Call | Defined | 2021-08-13 | |
| 2021-03-31 | $1,521,646 | 16,000 | Call | Defined | 2021-05-12 | |
| 2021-03-31 | $357,016 | 3,754 | Shares | Defined | 2021-05-12 | |
| 2021-03-31 | $7,256,351 | 76,300 | Put | Defined | 2021-05-12 | |
| 2020-12-31 | $323,909 | 5,221 | Shares | Defined | 2021-02-11 | |
| 2020-12-31 | $2,072,132 | 33,400 | Put | Defined | 2021-02-11 | |
| 2020-09-30 | $309,210 | 5,200 | Call | Defined | 2020-11-12 | |
| 2020-09-30 | $286,851 | 4,824 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $528,827 | 7,579 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $196,792 | 4,338 | Shares | Defined | 2020-05-01 | |
| 2020-03-31 | $476,331 | 10,500 | Call | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||